Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Consolidated Schedules to Balance Sheetas at 31st March 20<strong>11</strong>28 th <strong>Annual</strong> <strong>Report</strong>20<strong>10</strong> - <strong>11</strong>Company OverviewStrategic ReviewBoard and Management <strong>Report</strong>sFINANCIAL STATEMENTSAs At31st March 20<strong>11</strong>(` in Lacs)As At31st March 20<strong>10</strong>SCHEDULE <strong>11</strong>LOANS AND ADVANCES :(Unsecured, Considered Good)Loans and Advances 81.00 267.50 16,304.98 12,752.88Balance with Central Excise 433.66 465.66Advance Income Tax 2,055.71 1,451.0418,875.35 14,937.08SCHEDULE 12CURRENT LIABILITIES :Sundry Creditors :Total outstanding dues of micro and small enterprises 490.18 605.86(Refer Note No.5 in Schedule 20 )Total outstanding dues of creditors other than micro andsmall enterprises. 4306.73 3180.804,796.91 3,786.66 13,983.88 6,039.33Unclaimed Dividend* 30.27 31.22credited to the Investor Education and Protection Fund.18,8<strong>11</strong>.06 9,857.21SCHEDULE 13PROVISIONS :For Taxation 2,850.00 1,860.00For Proposed Dividend 616.09 565.72For Tax on Dividend 99.95 93.963,566.04 2,519.6887
Change language